Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well as broadening their potential field of use.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$35.75
Change (%) Stock is Down 2.71 (0.00%)
Volume4,549,780
Data as of 09/01/15 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
08/25/15
Download Documentation Corporate Presentation, August 2015

Recent News

More >>
DateTitle 
08/07/15Heron Therapeutics Announces Second Quarter 2015 Financial Results and Recent Corporate ProgressPrinter Friendly Version
07/23/15Heron Therapeutics Initiates Second Phase 2 Clinical Trial of HTX-011 for the Treatment of Post-Operative PainPrinter Friendly Version
07/20/15Heron Therapeutics Resubmits SUSTOL® New Drug Application to FDAPrinter Friendly Version
06/16/15Heron Therapeutics Initiates Phase 2 Clinical Trial of HTX-011 for the Treatment of Post-Operative PainPrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.